Exabis Library
Welcome to the e-CCO Library!
P462: Long-term outcomes of anti-TNF therapy discontinuation in patients with penetrating Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P462: Mucosal healing and deep remission rates with azathioprine in inflammatory bowel disease?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P462: Upfront infliximab dose intensification for secondary loss of response in IBD: similar efficacy to dose interval shortening with the added advantage of early clinical and pharmacokinetic predictors of response
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P463 Induction of endoscopic response: a network meta-analysis of induction studies comparing ontamalimab with other treatments for moderate-to-severe ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P463: Combination therapy of fresh faecal microbial transplantation and antibiotics for ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P463: COVID-19 vaccination willingness and hesitancy in patients with Inflammatory Bowel Diseases (IBD): analysis of determinants in a national survey of the Italian IBD patients’ association (AMICI Onlus).
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P463: Crohn's disease–associated anorectal cancer has a poor prognosis with high local recurrence: a subanalysis of the Nationwide Japanese Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P463: Factors to determine prognosis of intestinal cancer associated with Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P463: Long-term effects of anti-TNF therapy on bone metabolism
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P463: Recurrence of Crohn's disease after the first surgical intervention
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P463: Serum and mucosal Serpin E1 concentration correlates with endoscopic activity in inflammatory bowel disease - potential new activity marker
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P464 Vedolizumab concentrations in colonic mucosal tissue of ulcerative colitis patients inversely correlate with the severity of inflammation
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P464: Assessing medication adherence in patients with inflammatory bowel disease: what do we choose, self-adherence scales or pharmacy rates?
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P464: Effects of ozanimod on histologic remission and mucosal healing over 3 years of continuous treatment in patients with ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P464: Rac1/pSTAT3 expression in T lymphocytes: A potential pharmacodynamic marker for thiopurines in the treatment of Inflammatory Bowel Disease patients?
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P464: Recurrence of ulcerative colitis during pregnancy in patients who became pregnant during remission
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P464: Steroid dependency in patients with Ulcerative Colitis treated with advanced therapies in a German real-world-setting
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P464: Study of the usual aetiologies of methotrexate and azathioprine discontinuation in inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P464: Switching from the originator infliximab to biosimilar CT-P13 did not change the quality of life and clinical efficacy for IBD patients in stable remission in daily clinical practice (interim analysis)
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P465 Therapeutic drug monitoring in Crohn’s disease patients, a comparison between homogeneous mobility shift assay and point of care method
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM